» Articles » PMID: 2674169

Effect of the NMDA Antagonist MK-801 on Local Cerebral Blood Flow in Focal Cerebral Ischaemia in the Rat

Overview
Publisher Sage Publications
Date 1989 Oct 1
PMID 2674169
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of MK-801 upon local CBF after permanent middle cerebral artery (MCA) occlusion have been examined using [14C]iodoantipyrine autoradiography in halothane-anaesthetised rats. MK-801 (0.5 mg kg-1 i.v.) or saline was administered 30 min before MCA occlusion and CBF measured approximately 40 min after occlusion. In the hemisphere contralateral to the occluded MCA, MK-801 significantly reduced local CBF in 19 of the 22 regions examined from the levels in saline-treated rats. In the contralateral hemisphere, after treatment with MK-801, blood flow was reduced by an average of 37% with little variation in the magnitude of the reductions in different regions. In the hemisphere ipsilateral to MCA occlusion, MK-801 reduced CBF in almost every region located outside the territory of the occluded MCA. Within the territory of the occluded MCA, blood flow in the MK-801-treated rat did not significantly differ from values in vehicle-treated rats in any of the five cortical areas examined, although in the caudate nucleus there was a tendency for CBF to be lower in rats pretreated with MK-801. MK-801 had no effect on the amount of hypoperfused cerebral tissue (CBF less than 30 ml 100 g-1 min-1) in the ipsilateral hemisphere at any coronal plane examined; e.g., at coronal plane anterior 7.2 mm, 51 +/- 5% of the hemisphere displayed CBF of less than 30 ml 100 g-1 min-1 in saline-treated rats with MCA occlusion compared with 52 +/- 8% of the hemisphere in rats treated with MK-801 prior to MCA occlusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Glycine-induced NMDA receptor internalization provides neuroprotection and preserves vasculature following ischemic stroke.

Cappelli J, Khacho P, Wang B, Sokolovski A, Bakkar W, Raymond S iScience. 2022; 25(1):103539.

PMID: 34977503 PMC: 8689229. DOI: 10.1016/j.isci.2021.103539.


Targeting RNS/caveolin-1/MMP signaling cascades to protect against cerebral ischemia-reperfusion injuries: potential application for drug discovery.

Chen H, Chen X, Li W, Shen J Acta Pharmacol Sin. 2018; 39(5):669-682.

PMID: 29595191 PMC: 5943912. DOI: 10.1038/aps.2018.27.


Enhancing Nervous System Recovery through Neurobiologics, Neural Interface Training, and Neurorehabilitation.

Krucoff M, Rahimpour S, Slutzky M, Edgerton V, Turner D Front Neurosci. 2017; 10:584.

PMID: 28082858 PMC: 5186786. DOI: 10.3389/fnins.2016.00584.


Spreading Depression, Spreading Depolarizations, and the Cerebral Vasculature.

Ayata C, Lauritzen M Physiol Rev. 2015; 95(3):953-93.

PMID: 26133935 PMC: 4491545. DOI: 10.1152/physrev.00027.2014.


Involvement of bradykinin in brain edema development after ischemic stroke.

Dobrivojevic M, Spiranec K, Sindic A Pflugers Arch. 2014; 467(2):201-12.

PMID: 24756199 DOI: 10.1007/s00424-014-1519-x.